News & insights

Stay up to date with our latest products, technologies and company news, and meet our teams at upcoming events. We also share insights from consumer testing, scientific data and market trends across a broad range of application areas.

MedCan Pharma changes name to NordicCan

Full Contract Development and Manufacturing Organization will continue to specialize in innovative cannabinoid solutions for the B2B market MedCan Pharma A/S announced today the launch of a new corporate name and brand identity. The organization will now be known...

2019-07-10

Exploring the potential of the cannabis business

The global market for medicinal use of cannabis is expected to grow to a multi-billion dollar market over the coming years. This is primarily due to the cannabis legislation currently being under review or already changing in many countries...

2019-07-01

Fertin Pharma’s parent company acquires NordicCan – allowing entry into fast-growing market for cannabinoid products

Claudio Bidco A/S (the “Parent Company”), the parent company of Fertin Pharma A/S (“Fertin Pharma”) has signed and closed the acquisition of NordicCan A/S (“NordicCan”), a research organisation focusing on developing innovative products containing cannabinoids with a primary focus...

2019-07-01

Fertin Pharma acquires Tab Labs – provides the combined group a unique CDMO position in the North American dietary supplement market

Fertin Pharma A/S (“Fertin Pharma”) has signed and closed the acquisition of Tab Labs Inc. (“Tab Labs”), a leader in compressed gum and mints / lozenges and one of the largest contracts tableting companies in North America servicing customers...